Literature DB >> 18538444

The chemistry of irreversible capture.

Claude F Meares1.   

Abstract

The specific recognition and binding of biological molecules by antibodies is fundamentally important. Natural antibodies are multivalent, having at least two identical ligand-binding sites; this permits them to bind tightly at cell surfaces, which present multiple copies of their target ligands. Antibodies that bind to soluble monovalent ligands, such as most small molecules, do not share this multivalent advantage. Nor do engineered fragments of antibodies, such as single-chain Fv proteins or Fab fragments, which generally possess only a single ligand-binding site. Engineered monovalent antibody/ligand pairs that retain the binding specificity of the antibody, but do not dissociate, are promising components of new delivery systems. These are based on a combination of genetic manipulation of the protein and chemical synthesis of appropriate ligands, examples of which are reviewed here.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18538444      PMCID: PMC2543059          DOI: 10.1016/j.addr.2008.04.010

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  29 in total

1.  Selective inhibition of engineered receptors via proximity-accelerated alkylation.

Authors:  Konstantin Levitsky; Christopher J Ciolli; Peter J Belshaw
Journal:  Org Lett       Date:  2003-03-06       Impact factor: 6.005

2.  Reactivity of functional groups on the protein surface: development of epoxide probes for protein labeling.

Authors:  Gong Chen; Alexander Heim; Doris Riether; Dominic Yee; Yelena Milgrom; Mary Ann Gawinowicz; Dalibor Sames
Journal:  J Am Chem Soc       Date:  2003-07-09       Impact factor: 15.419

3.  Introduction of nucleophiles and spectroscopic probes into antibody combining sites.

Authors:  S J Pollack; G R Nakayama; P G Schultz
Journal:  Science       Date:  1988-11-18       Impact factor: 47.728

4.  Mechanism of penicillin action: penicillin and substrate bind covalently to the same active site serine in two bacterial D-alanine carboxypeptidases.

Authors:  R R Yocum; D J Waxman; J R Rasmussen; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-06       Impact factor: 11.205

5.  Electrophilic chelating agents for irreversible binding of metal chelates to engineered antibodies.

Authors:  A J Chmura; Brian D Schmidt; Donald T Corson; Stacey L Traviglia; Claude F Meares
Journal:  J Control Release       Date:  2002-01-17       Impact factor: 9.776

6.  A rare earth-DOTA-binding antibody: probe properties and binding affinity across the lanthanide series.

Authors:  Todd M Corneillie; Paul A Whetstone; Andrew J Fisher; Claude F Meares
Journal:  J Am Chem Soc       Date:  2003-03-26       Impact factor: 15.419

7.  Crystal structures of two complexes of the rare-earth-DOTA-binding antibody 2D12.5: ligand generality from a chiral system.

Authors:  Todd M Corneillie; Andrew J Fisher; Claude F Meares
Journal:  J Am Chem Soc       Date:  2003-12-10       Impact factor: 15.419

8.  Structure-activity relationships for mitomycin C and mitomycin A analogues.

Authors:  K R Kunz; B S Iyengar; R T Dorr; D S Alberts; W A Remers
Journal:  J Med Chem       Date:  1991-07       Impact factor: 7.446

9.  Site-directed mutants of a soluble form of penicillin-binding protein 5 from Escherichia coli and their catalytic properties.

Authors:  R A Nicholas; J L Strominger
Journal:  J Biol Chem       Date:  1988-02-05       Impact factor: 5.157

10.  Antibodies against metal chelates.

Authors:  D T Reardan; C F Meares; D A Goodwin; M McTigue; G S David; M R Stone; J P Leung; R M Bartholomew; J M Frincke
Journal:  Nature       Date:  1985 Jul 18-24       Impact factor: 49.962

View more
  2 in total

1.  Precision Modification of Native Antibodies.

Authors:  Kuan-Lin Wu; Chenfei Yu; Catherine Lee; Chao Zuo; Zachary T Ball; Han Xiao
Journal:  Bioconjug Chem       Date:  2021-08-24       Impact factor: 4.774

2.  High efficiency diffusion molecular retention tumor targeting.

Authors:  Yanyan Guo; Hushan Yuan; Hoonsung Cho; Darshini Kuruppu; Kimmo Jokivarsi; Aayush Agarwal; Khalid Shah; Lee Josephson
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.